The ratings system also affirmed the “A2” rating on WVU Medicine’s $468 million of outstanding bonds.
The rating affirmation and assignment are based on a number of factors, including WVU Medicine’s status as the largest healthcare system in the state, formidable market position and sustained strong operating momentum.
The outlook is stable, reflecting Moody’s Investors Service’s expectation WVU Medicine will maintain an operating performance in line with recent levels, sufficient to slowly grow liquidity measures and cover near-term capital and strategic investment needs.
More articles on healthcare finance:
Moody’s affirms ‘A1’ rating on Jackson-Madison County General Hospital’s outstanding debt
Moody’s assigns ‘A1’ rating to Children’s Hospital & Medical Center’s bonds
Moody’s assigns ‘Caa1’ rating to Good Shepherd Health System’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
